论文部分内容阅读
多发性骨髓瘤(MM)是一种起源于骨髓单克隆浆细胞的恶性增生肿瘤性疾病。临床上治疗骨髓瘤方案虽多,但并无高效者。作者2004年12月~2006年2月使用沙利度胺(反应停)治疗多发性骨髓瘤(MM)19例,取得满意疗效,现总结如下。1资料与方法本组病例19例,均为住本院确诊为多发性骨髓瘤患者
Multiple myeloma (MM) is a malignant proliferative neoplastic disease that originates from bone marrow monoclonal plasma cells. Clinical treatment of myeloma though many programs, but no efficient person. The author from December 2004 to February 2006 with thalidomide (response to stop) treatment of multiple myeloma (MM) in 19 cases, and achieved satisfactory results, are summarized as follows. 1 Materials and Methods 19 patients in this group were admitted to hospital for the diagnosis of multiple myeloma patients